Direct Cost analysis of women with breast cancer in Côte d’Ivoire, 2022.

Authors

  • Edele Kacou AKA University Felix Houphouet Boigny Abidjan
  • Bangaman Christian AKANI
  • Kakou Arnauld Gomez
  • Coulibaly DIDI-KOUKO
  • Apollinaire HORO

Keywords:

Cost analysis, breast cancer, Cote d’Ivoire

Abstract

The management of breast cancer is a major economic burden in countries with limited resources. The aim was to estimate the direct medical costs of patients treated for breast cancer in the Ivory Coast. A cross-sectional study was designed and carried out in the main referral health facilities for gynaecology-obstetrics and oncology in the Ivory Coast. The study included patients with histologically confirmed breast cancer. Data were collected from medical records and patient interviews. A total of 102 patients at different stages of the disease were included in the study. Costs increase in advanced stages. Chemotherapy was the main cost factor ($3,121 per patient), followed by radiotherapy ($1,714). Women with breast cancer faced an estimated average cost of $442 (ranging from $322 to $933). The cost of radiotherapy was also exorbitant ($1,714 per patient). Surgery was the least expensive treatment ($1,416). The average total cost of radiological examinations and laboratory tests was $304 and $247 respectively. Follow-up care was estimated at $631. This study provides an insightful analysis that will serve as a basis for further economic evaluation and could also be useful to healthcare decision-makers for inclusion in the national health coverage plan.

References

Andrianisa, H. A., Brou, Y. O. K., & Séhi bi, A. (2016). Role and importance of informal collectors in the municipal waste pre-collection system in Abidjan, Côte d’Ivoire. Habitat International, 53, 265–273. https://doi.org/10.1016/j.habitatint.2015.11.036

Anyanwu, S. N. (2008). Temporal trends in breast cancer presentation in the third world. Journal of Experimental & Clinical Cancer Research, 27(1), 17. https://doi.org/10.1186/1756-9966-27-17

Blumen, H., Fitch, K., & Polkus, V. (2016). Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service. American Health & Drug Benefits, 9(1), 23–32.

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492

Capri, S., & Russo, A. (2017). Cost of breast cancer based on real-world data: A cancer registry study in Italy. BMC Health Services Research, 17, 84. https://doi.org/10.1186/s12913-017-2006-9

Curado, M. P. (2011). Breast cancer in the world: Incidence and mortality. Salud Pública de México, 53(5).

Davari, M., Yazdanpanah, F., Aslani, A., Hosseini, M., Nazari, A. R., & Mokarian, F. (2013). The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient’s Level Data from a Cancer Specific Hospital in Isfahan. International Journal of Preventive Medicine, 4(7), 748–754.

Diallo, M., Fall, D., Mballo, I., Niang, C. I., & Charfi, M. E. (2022). Coûts médicaux directs de traitement du cancer du sein à l’Institut Joliot Curie de l’hôpital Aristide Le Dantec de Dakar, Sénégal. 18.

Fitch, M. I., Nicoll, I., & Keller-Olaman, S. (2007). Stratégies de diffusion de l’information sur le cancer du sein – Trouver ce qui fonctionne. Canadian Oncology Nursing Journal / Revue canadienne de soins infirmiers en oncologie, 17(4), Article 4.

González-Robledo MC, Wong R, Ornelas HA, Knaul FM. (2015). Coûts des soins de cancer du sein au Mexique: analyse de deux scenarios de couverture d'assurance. E cancer medical science; 9: 587.

Hoang Lan, N., Laohasiriwong, W., Stewart, J. F., Tung, N. D., & Coyte, P. C. (2013). Cost of treatment for breast cancer in central Vietnam. Global Health Action, 6, 10.3402/gha.v6i0.18872. https://doi.org/10.3402/gha.v6i0.18872

Hughes, G., Amoah, A., Ahiabor, G., & Awuah, B. (2012). Economic Cost of Breast Cancer in Ghana: The Komfo Anokye Teaching Hospital Experience. Journal of Business Research, 6(1–2), Article 1–2. https://doi.org/10.4314/jbr.v6i1-2

Ivanauskienė, R., Domeikienė, A., Kregždytė, R., Milašauskienė, Ž., & Padaiga, Ž. (2015). The cost of newly diagnosed breast cancer in Lithuania, 2011. Medicina, 51(1), 63–68. https://doi.org/10.1016/j.medici.2015.01.002

Kim, P. (2007). Cost of Cancer Care: The Patient Perspective. Journal of Clinical Oncology, 25(2), 228–232. https://doi.org/10.1200/JCO.2006.07.9111

Lidgren, B., Mathias et Wilking, Nils et Jönsson. (2002). Coût du cancer du sein en Suède en. Le Journal Européen de l’économie de La Santé, 8, 5–15.

Miadi-Fargier, H., Le Pen, C., Guastalla, J. P., Pivot, X., Woronoff-Lemsi, M. C., Roché, H., ... & De Pouvourville, G. (2009). Impact médico-économique du docétaxel dans le traitement adjuvant du cancer du sein. Journal de gestion et d’économie médicales, 27(7), 435-449.

Mosomi, J. (2019). An empirical analysis of trends in female labour force participation and the gender wage gap in South Africa. Agenda, 33(4), 29–43. https://doi.org/10.1080/10130950.2019.1656090

Mousa, R., hammad, E., Melhem, J., & Al-Jaghbir, M. (2021). Direct medical costs of breast cancer in Jordan: Cost drivers and predictors. Expert Review of Pharmacoeconomics & Outcomes Research, 21(4), 647–654. https://doi.org/10.1080/14737167.2021.1859372

Nkondjock, A., & Ghadirian, P. (2005). Facteurs de risque du cancer du sein. médecine/sciences, 21(2), Article 2. https://doi.org/10.1051/medsci/2005212175

O’Neill, R., Kathleen M. et Mandigo, Morgan et Pyda, Jordan et Nazaire, Yolande et Greenberg, Sarah LM et Gillies, Rowan et Damuse. (n.d.). Dépenses personnelles encourues par les patientes obtenant des soins gratuits contre le cancer du sein en Haïti: Une étude pilote. Chirurgie, 158, 747–755.

Philip, T., Kasparian, C., Fagnani, F., Moatti, J.-P., & Meunier, A. (2005). Le dépistage du cancer du sein en France: Bilan et limites. Bulletin de l’Académie Nationale de Médecine, 189(2), 321–339. https://doi.org/10.1016/S0001-4079(19)33587-3

Rojas, K., & Stuckey, A. (2016). Breast cancer epidemiology and risk factors. Clinical Obstetrics and Gynecology, 59(4), 651–672.

Subramanian, S., Trogdon, J., Ekwueme, D. U., Gardner, J. G., Whitmire, J. T., & Rao, C. (2011). Cost of Breast Cancer Treatment in Medicaid: Implications for State Programs Providing Coverage for Low-Income Women. Medical Care, 49(1), 89–95. https://doi.org/10.1097/MLR.0b013e3181f81c32

Sun, L., Legood, R., dos-Santos-Silva, I., Gaiha, S. M., & Sadique, Z. (2018). Global treatment costs of breast cancer by stage: A systematic review. PLOS ONE, 13(11), e0207993. https://doi.org/10.1371/journal.pone.0207993

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660

Tai, B.-W. B., Bae, Y. H., & Le, Q. A. (2016). A Systematic Review of Health Economic Evaluation Studies Using the Patient’s Perspective. Value in Health, 19(6), 903–908. https://doi.org/10.1016/j.jval.2016.05.010

The World Bank. (n.d.). PIB par habitant, ($ PPA internationaux courants)—Cote d’Ivoire | Data. Retrieved March 3, 2023, from https://donnees.banquemondiale.org/indicator/NY.GDP.PCAP.PP.CD?locations=CI

USAID. (2019). A guide to the fundementals of economic evaluation in public health.pdf. https://www.measureevaluation.org/resources/publications/ms-19 162/at_download/document

Walley, T., & Haycox, A. (1997). Pharmacoeconomics: Basic concepts and terminology. British Journal of Clinical Pharmacology, 43(4), 343–348. https://doi.org/10.1046/j.1365-2125.1997.00574.x

WHO. (2020). Côte d’Ivoire, Globocan 2020. https://gco.iarc.fr/today/data/factsheets/populations/384-cote-divoire-fact-sheets.pdf

World bank institute. (2021). Data for Cote d’Ivoire, Lower middle income | Data. https://data.worldbank.org/?locations=CI-XN

Xu, K., Evans, D. B., Kawabata, K., Zeramdini, R., Klavus, J., & Murray, C. J. (2003). Household catastrophic health expenditure: A multicountry analysis. The Lancet, 362(9378), 111–117. https://doi.org/10.1016/S0140-6736(03)13861-5

Zelle, S. G., Nyarko, K. M., Bosu, W. K., Aikins, M., Niëns, L. M., Lauer, J. A., …… & Baltussen, R. (2012). Costs, effects and cost-effectiveness of breast cancer control in Ghana: Breast cancer control Ghana. Tropical Medicine & International Health, 17(8), 1031–1043. https://doi.org/10.1111/j.1365-3156.2012.03021.x

Downloads

Published

2023-08-25

How to Cite

AKA, E. K., Akani , B. C. ., ZOUA, K. A. G., DIDI-KOUKO, C., & HORO, A. (2023). Direct Cost analysis of women with breast cancer in Côte d’Ivoire, 2022. Revue Africaine Des Sciences Sociales Et De La Santé Publique, 5(2), 48-61. Retrieved from https://revue-rasp.org/index.php/rasp/article/view/415

Issue

Vol. 5 No. 2 (2023): July - December 2023

Section

Articles

ARK

http://www.revue-rasp.org/index/ark:/00000/RASP.v5i2.04

License

Copyright (c) 2023 Edele Kacou AKA, Bangaman Christian Akani , Kakou Arnauld Gomez ZOUA, Coulibaly DIDI-KOUKO, Apollinaire HORO

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

https://creativecommons.org/licenses/by/4.0/

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.
  • The licensor cannot revoke these freedoms as long as you follow the license terms